Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-24 @ 5:31 PM
NCT ID:
NCT03619668
Eligibility Criteria:
Inclusion Criteria:
All patients referred to standard chemoradiotherapy for locally advanced rectal cancer.
Exclusion Criteria:
* Prior surgery in pelvic minor region
* Pacemaker
* Neurostimulator
* Other non MR-compatible implants
* Pregnancy
* Incapable of undergoing MRI
* Incapable of understanding the patient information
* Allergic to contrast agent
* Contraindication for Buscopan
* Reduced renal function (GFR \< 50 ml/min) Patients who cannot tolerate the contrast used for DCE-MRI (due to allergies, contraindications for Buscopan or reduced renal function (GFR \< 50 ml/min)) will still be offered inclusion in the study, but without the contrast-based MRI scans.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03619668
Study Brief:
Protocol Section:
NCT03619668